Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 543213 | NSE Symbol : ROSSARI | ISIN : INE02A801020 | Industry : Chemicals |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
17-Apr-2025	25-Apr-2025	Accounts	Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2025 inter alia to consider and approve 1. Audited Financial Statements and Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31 2025. 2. recommend payment of Final Dividend if any for the Financial Year ended March 31 2025. Outcome of Board Meeting held on April 25, 2025. (As Per BSE Announcement Dated on: 25/04/2025)
13-Jan-2025	21-Jan-2025	Quarterly Results	Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2025 ,inter alia, to consider and approve Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31, 2024 Outcome of Board Meeting held on January 21, 2025. Allotment of 7500 Equity shares under Rossari Employee Stock Option Plan -2019. (As Per Bse Announcement Dated on 21.01.2025)
30-Nov-2024	30-Nov-2024	Subsidiary Company	The Board of Directors have inter alia approved Incorporation of wholly owned subsidiary in Kingdom of Saudi Arabia and other matters.
11-Oct-2024	19-Oct-2024	Quarterly Results	Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2024 inter alia to consider and approve Unaudited Financial Results (Standalone And Consolidated) For the quarter and half year ended September 30 2024 Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2024 - (Readable) (As per BSE Announcement Dated on 19/10/2024)
12-Jul-2024	20-Jul-2024	Quarterly Results	Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2024 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2024 The Board of Directors have inter alia approved the Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2024. (As Per BSE Announcement dated on 20.07.2024)
20-Apr-2024	29-Apr-2024	Quarterly Results	ROSSARI BIOTECH LIMITED has informed BSE about Board Meeting to be held on 29 Apr 2024 to consider financial statements for the period ended March 2024. Financial results / Dividend. Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2024 ,inter alia, to consider and approve Audited Financial Statements and Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31st March, 2024 and recommend payment of Final Dividend for the Financial Year ended 31.03.2024. The Board of Directors have inter alia approved the Audited Financial Results and Statements (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2024 and Final Dividend for the Financial Year 2023-24 Final Dividend of 25% (i.e. Re. 0.50/- per share) on Equity Shares of the Face Value of Rs. 2/- each for the Financial Year ended March 31, 2024, subject to approval of the Members of the Company at the ensuing Annual General Meeting ('AGM') of the Company. Information regarding Book closure and record date for payment of Final dividend will be intimated separately. Audited Financial Results and Statements (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2024. Intimation of Allotment of 1500 Equity shares under Rossari Employee Stock Option Plan-2019. (As Per BSE Announcement dated on 29.04.2024)
06-Apr-2024	06-Apr-2024	Change in Other Executives	The Board of Directors have inter alia approved Incorporation of wholly owned subsidiary in Dubai, United Arab Emirates and Appointment of Mr. Sunil V as Chief Human Resource Officer and other matters
12-Jan-2024	20-Jan-2024	Quarterly Results	Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/01/2024 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2023. Rossari Biotech Limited has informed the Exchange regarding Board meeting held on January 20, 2024. The Board of Directors have interalia approved Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2023 and other matters. The Board of Directors of the Company at their meeting held on January 20, 2024, have interalia approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2023. (Revised) (As Per BSE Announcement dated on 20.01.2024)
20-Jan-2024	20-Jan-2024	Employee Stock Option	Rossari Biotech Limited has informed the exchange regarding allotment of 9350 shares.
13-Oct-2023	21-Oct-2023	Quarterly Results	Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2023 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30 2023. The Board of Directors have Inter alia approved Unaudited Financial Results (Standalone and Consolidated) for the Quarter and half year ended September 30, 2023 of the Financial Year 2023-24 and other matters. (As Per BSE Announcement dated on 21.10.2023)
21-Jul-2023	29-Jul-2023	Quarterly Results	Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2023 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2023. The Board of Directors have Inter alia approved Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2023 of the Financial Year 2023-24 and other matters. (As Per BSE Announcement Dated on 30.07.2023)
05-May-2023	05-May-2023	AGM	Outcome of Board Meeting held on Friday, May 05, 2023 in compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
22-Apr-2023	29-Apr-2023	Accounts	Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2023 inter alia to consider and approve Audited Financial Statements and Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31 2023 and Dividend (if any) The Board of Directors have Inter alia approved Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2023 of the Financial Year 2022-23 and other matters. (As Per BSE Announcement Dated on 29.04.2023)
25-Jan-2023	04-Feb-2023	Quarterly Results	Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2023 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2022. The Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2022 for the Financial Year 2022-23 and other matters. The Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2022 for the Financial Year 2022-23 and other matters. (As Per BSE Announcement Dated on 04.02.2023)
31-Oct-2022	05-Nov-2022	Quarterly Results	Quarterly Results Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2022 ,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2022. (As Per BSE Announcement Dated on 28.10.2022) The Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2022 for the Financial Year 2022-23 and other matters. (As Per BSE Announcement Dated 05.11.2022)

1 2

LOGIN HERE

Rossari Biotech Ltd

Board Meeting